Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo

Journal of Molecular and Cellular Cardiology

Volumn 97, Issue , 2016, Pages 235-244

  Fanton, Yanick ^a,b   Houbrechts, Cynthia ^b   Willems, Leen ^a,b   Daniëls, Annick ^a   Linsen, Loes ^c   Ratajczak, Jessica ^b   Bronckaers, Annelies ^b   Lambrichts, Ivo ^b   Declercq, Jeroen ^a,b   Rummens, Jean Luc ^a,b   Hendrikx, Marc ^a,b   Hensen, Karen ^a,b  

^a JESSA HOSPITAL   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiogenesis; Cardiac progenitor cells; Endothelial cell; Growth factors and cytokines; Stem cell

Indexed keywords

ENDOTHELIN 1; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN; ANGIOGENIC FACTOR; BIOLOGICAL MARKER; CONDITIONED MEDIUM; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CARDIAC ATRIAL APPENDAGE STEM CELL; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHORIOALLANTOIC MEMBRANE ASSAY; CONTROLLED STUDY; HEART ATRIUM APPENDAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL; ANIMAL; CELL CULTURE; CHICK EMBRYO; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHARMACOLOGY; PROCEDURES; PROTEOMICS; SECRETION (PROCESS); TISSUE MICROARRAY;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ATRIAL APPENDAGE; BIOMARKERS; CELLS, CULTURED; CHICK EMBRYO; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENDOTHELIN-1; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOMICS; STEM CELLS; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84975322655     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.06.005     Document Type: Article

References (43)

1. Barcelos L.S., Duplaa C., Krankel N., Graiani G., Invernici G., Katare R., Siragusa M., Meloni M., Campesi I., Monica M., Simm A., Campagnolo P., Mangialardi G., Stevanato L., Alessandri G., Emanueli C., Madeddu P. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res. 2009, 104:1095-1102. 10.1161/CIRCRESAHA.108.192138.
2. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
3. Boodhwani M., Sodha N.R., Laham R.J., Sellke F.W. The future of therapeutic myocardial angiogenesis. Shock 2006, 26:332-341. 10.1097/01.shk.0000225318.08681.a7.
4. Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 2000, 102:IV14-IV23.
5. Bronckaers A., Hilkens P., Fanton Y., Struys T., Gervois P., Politis C., Martens W., Lambrichts I. Angiogenic properties of human dental pulp stem cells. PLoS One 2013, 8. 10.1371/journal.pone.0071104.
6. Burchfield J.S., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008, 1:4. 10.1186/1755-1536-1-4.
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395. 10.1038/74651.
8. Carpentier G. Angiogenesis Analyzer for ImageJ 2012, Gilles Carpentier Research Web Site: Computer Image Analysis.
9. Cheng K., Malliaras K., Smith R.R., Shen D., Sun B., Blusztajn A., Xie Y., Ibrahim A., Aminzadeh M.A., Liu W., Li T.S., De Robertis M.A., Marban L., Czer L.S., Trento A., Marban E. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Heart Fail 2014, 2:49-61. 10.1016/j.jchf.2013.08.008.
10. Chimenti I., Smith R.R., Li T.S., Gerstenblith G., Messina E., Giacomello A., Marban E. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 2010, 106:971-980. 10.1161/CIRCRESAHA.109.210682.
11. Choi M., Lee H.S., Naidansaren P., Kim H.K., O E, Cha J.H., Ahn H.Y., Yang P.I., Shin J.C., Joe Y.A. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int. J. Biochem. Cell Biol. 2013, 45:560-570. 10.1016/j.biocel.2012.12.001.
12. Fanton Y., Robic B., Rummens J.L., Daniels A., Windmolders S., Willems L., Jamaer L., Dubois J., Bijnens E., Heuts N., Notelaers K., Paesen R., Ameloot M., Mees U., Bito V., Declercq J., Hensen K., Koninckx R., Hendrikx M. Cardiac atrial appendage stem cells engraft and differentiate into cardiomyocytes in vivo: a new tool for cardiac repair after MI. Int. J. Cardiol. 2015, 201:10-19. 10.1016/j.ijcard.2015.07.066.
13. Frangogiannis N.G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 2012, 110:159-173. 10.1161/CIRCRESAHA.111.243162.
14. Gelman A. Why We (usually) don't have to worry about multiple comparisons. J. Res. Educ. Eff. 2012, 5:189-211.
15. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219. 10.1161/CIRCRESAHA.108.176826.
16. Granata R., Trovato L., Lupia E., Sala G., Settanni F., Camussi G., Ghidoni R., Ghigo E. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J. Thromb. Haemost. 2007, 5:835-845. 10.1111/j.1538-7836.2007.02431.x.
17. Gruber R., Kandler B., Holzmann P., Vogele-Kadletz M., Losert U., Fischer M.B., Watzek G. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng. 2005, 11:896-903. 10.1089/ten.2005.11.896.
18. Hendrikx M., Hensen K., Clijsters C., Jongen H., Koninckx R., Bijnens E., Ingels M., Jacobs A., Geukens R., Dendale P., Vijgen J., Dilling D., Steels P., Mees U., Rummens J.L. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006, 114:I101-I107. 114/1_suppl/I-101 [pii]. 10.1161/CIRCULATIONAHA.105.000505.
19. Hilkens P., Fanton Y., Martens W., Gervois P., Struys T., Politis C., Lambrichts I., Bronckaers A. Pro-angiogenic impact of dental stem cells in vitro and in vivo. Stem Cell Res. 2014, 12:778-790. 10.1016/j.scr.2014.03.008.
20. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., Nurzynska D., Kasahara H., Zias E., Bonafe M., Nadal-Ginard B., Torella D., Nascimbene A., Quaini F., Urbanek K., Leri A., Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 2005, 96:127-137. 10.1161/01.RES.0000151843.79801.60.
21. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 2004, 94:678-685. 10.1161/01.RES.0000118601.37875.AC.
22. Koninckx R., Daniels A., Windmolders S., Mees U., Macianskiene R., Mubagwa K., Steels P., Jamaer L., Dubois J., Robic B., Hendrikx M., Rummens J.L., Hensen K. The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair. Cardiovasc. Res. 2013, 97:413-423. (cvs427 [pii). 10.1093/cvr/cvs427.
23. Lee M.Y., Huang J.P., Chen Y.Y., Aplin J.D., Wu Y.H., Chen C.Y., Chen P.C., Chen C.P. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS One 2009, 4. 10.1371/journal.pone.0006913.
24. Li T.S., Cheng K., Malliaras K., Smith R.R., Zhang Y., Sun B., Matsushita N., Blusztajn A., Terrovitis J., Kusuoka H., Marban L., Marban E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol. 2012, 59:942-953. 10.1016/j.jacc.2011.11.029.
25. Liang S.X., Khachigian L.M., Ahmadi Z., Yang M., Liu S., Chong B.H. In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells). J. Thromb. Haemost. 2011, 9:1628-1637. 10.1111/j.1538-7836.2011.04375.x.
26. Liu B., Lee K.W., Anzo M., Zhang B., Zi X., Tao Y., Shiry L., Pollak M., Lin S., Cohen P. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 2007, 26:1811-1819. 10.1038/sj.onc.1209977.
27. Malliaras K., Kreke M., Marban E. The stuttering progress of cell therapy for heart disease. Clin. Pharmacol. Ther. 2011, 90:532-541. 10.1038/clpt.2011.175.
28. Markel T.A., Wang Y., Herrmann J.L., Crisostomo P.R., Wang M., Novotny N.M., Herring C.M., Tan J., Lahm T., Meldrum D.R. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2308-H2314. 10.1152/ajpheart.00565.2008.
29. Matsuura K., Honda A., Nagai T., Fukushima N., Iwanaga K., Tokunaga M., Shimizu T., Okano T., Kasanuki H., Hagiwara N., Komuro I. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J. Clin. Invest. 2009, 119:2204-2217. 10.1172/JCI37456.
30. Miyamoto S., Kawaguchi N., Ellison G.M., Matsuoka R., Shin'oka T., Kurosawa H. Characterization of long-term cultured c-kit + cardiac stem cells derived from adult rat hearts. Stem Cells Dev. 2010, 19:105-116. 10.1089/scd.2009.0041.
31. Nishishita T., Ouchi K., Zhang X., Inoue M., Inazawa T., Yoshiura K., Kuwabara K., Nakaoka T., Watanabe N., Igura K., Takahashi T.A., Yamashita N. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells. Biochem. Biophys. Res. Commun. 2004, 325:24-31. 10.1016/j.bbrc.2004.10.003.
32. Renault M.A., Losordo D.W. Therapeutic myocardial angiogenesis. Microvasc. Res. 2007, 74:159-171. 10.1016/j.mvr.2007.08.005.
33. Ribatti D. The chick embryo chorioallantoic membrane as a model for tumor biology. Exp. Cell Res. 2014, 328:314-324. 10.1016/j.yexcr.2014.06.010.
34. Ribatti D., Gualandris A., Bastaki M., Vacca A., Iurlaro M., Roncali L., Presta M. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J. Vasc. Res. 1997, 34:455-463.
35. Roubelakis M.G., Tsaknakis G., Pappa K.I., Anagnou N.P., Watt S.M. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS One 2013, 8. 10.1371/journal.pone.0054747.
36. Roy S., Khanna S., Bickerstaff A.A., Subramanian S.V., Atalay M., Bierl M., Pendyala S., Levy D., Sharma N., Venojarvi M., Strauch A., Orosz C.G., Sen C.K. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ. Res. 2003, 92:264-271.
37. Salani D., Taraboletti G., Rosano L., Di Castro V., Borsotti P., Giavazzi R., Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol. 2000, 157:1703-1711. 10.1016/S0002-9440(10)64807-9.
38. Song G., Li X., Shen Y., Qian L., Kong X., Chen M., Cao K., Zhang F. Transplantation of iPSc restores cardiac function by promoting angiogenesis and ameliorating cardiac remodeling in a post-infarcted swine model. Cell Biochem. Biophys. 2014, 10.1007/s12013-014-0369-7.
39. Staton C.A., Reed M.W., Brown N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 2009, 90:195-221. 10.1111/j.1365-2613.2008.00633.x.
40. Tang X.L., Li Q., Rokosh G., Sanganalmath S., Chen N., Ou Q., Stowers H., Hunt G., Bolli R. Long-term outcome of administration of c-kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ. Res. 2016, 10.1161/CIRCRESAHA.115.307647.
41. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 2005, 39:733-742. 10.1016/j.yjmcc.2005.07.003.
42. Windmolders S., Willems L., Daniels A., Linsen L., Fanton Y., Hendrikx M., Koninckx R., Rummens J.L., Hensen K. Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells. Cell Prolif. 2015, 10.1111/cpr.12166.
43. Zhang Y., Sivakumaran P., Newcomb A.E., Hernandez D., Harris N., Khanabdali R., Liu G.S., Kelly D.J., Pebay A., Hewitt A.W., Boyle A., Harvey R., Morrison W.A., Elliott D.A., Dusting G.J., Lim S.Y. Cardiac repair with a novel population of mesenchymal stem cells resident in the human heart. Stem Cells 2015, 33:3100-3113. 10.1002/stem.2101.